Evidence map›Paper›PMID 41782069›Full record

ArticleResearch involvement and engagement2026

Development of a patient advocate committee for a pediatric biobank.

Frances Argento, Mackenzie Devlin, Serge Dorna, Kaitlyn Flegg, Michelle Prunier, Tim Regan, Ivana Ristevski, Lynn Tarabey, Helen Dimaras

Abstract read
In one paragraph

Article in Research involvement and engagement, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Frances ArgentoDepartment of Ophthalmology & Vision Sciences, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
Mackenzie DevlinPatient Partner, Kids Eye Biobank, Toronto, Canada.
Serge DornaPatient Partner, Kids Eye Biobank, Toronto, Canada.
Kaitlyn FleggDepartment of Ophthalmology & Vision Sciences, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
Michelle PrunierPatient Partner, Kids Eye Biobank, Toronto, Canada.
Tim ReganPatient Partner, Kids Eye Biobank, Toronto, Canada.
Ivana RistevskiPatient Partner, Kids Eye Biobank, Toronto, Canada.
Lynn TarabeyPatient Partner, Kids Eye Biobank, Toronto, Canada.
Helen DimarasDepartment of Ophthalmology & Vision Sciences, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada. Helen.dimaras@sickkids.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Kids Eye Biobank is a pediatric ophthalmology biobank with a dedicated eye cancer collection. It centralizes data (e.g., biological samples, images, and clinical data) for use in future research. Recognizing the importance of patient engagement in research, the Kids Eye Biobank was designed with a patient-centered governance model, which includes a patient advocate committee (PAC). This study describes the development of the PAC and its outputs.

methodsPatients (defined as anyone with lived experience of pediatric eye disease) were recruited by contacting pre-existing research partners, patient advocacy networks (e.g., Canadian Retinoblastoma Research Advisory Board), and biobank participants/families. A patient engagement plan was created to guide the PAC's work; PAC members refined and prioritized goals. The PAC reviewed the Kids Eye Biobank’s governance structure and were invited to sit on additional committees. Monthly PAC meetings were held, during which members worked on implementing goals outlined in the patient engagement plan.

resultsAs of August 2025, there were six PAC members; five live in North America and one lives outside of North America. Two members had eye cancer as children, three were parents of children with eye cancer, and one member had dual experience. The PAC held 19 virtual meetings. PAC members ranked goals within the patient engagement plan, choosing to focus efforts on Biobank participant recruitment, PAC member mentorship, and contributing lived experience to the Kids Eye Biobank’s informed consent process. A “Participant Information Pamphlet” was reviewed and edited to recruit biobank participants. The PAC created an “Information Guide” to sensitize and train new patient partners. After reviewing the informed consent process, PAC members identified the need for and created a patient-centered tool to facilitate informed consent discussions. Additionally, three PAC members joined other governing committees to enhance the Kids Eye Biobank’s patient-oriented operations.

conclusionsPAC member commitment is demonstrated by regular meetings, project progression and involvement throughout the Kids Eye Biobank’s governance and operations. Patient partners made unique contributions from their lived experience to suggest enhancements to the Kids Eye Biobank’s communications, related to participant recruitment, PAC member mentorship, and the informed consent process.

Indexed as

BiobankGovernanceMethodologyOcular cancerOncologyOphthalmologyPatient advisory committeePatient and public involvementPatient engagementPediatric

Identifiers

PMID41782069
PMCPMC13069757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.